SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19

Caroline Hirsch; Sarah J. Valk; Vanessa Piechotta; Khai Li Chai; Lise J. Estcourt; Ina Monsef; Susanne Salomon; Eve Tomlinson; Maria Popp; Erica M. Wood; Cynthia So-Osman; David J. Roberts; Zoe McQuilten; Nicole Skoetz; Nina Kreuzberger

doi:10.1002/14651858.CD014945

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19

Caroline Hirsch^*, Sarah J. Valk, Vanessa Piechotta, Khai Li Chai, Lise J. Estcourt, Ina Monsef, Susanne Salomon, Eve Tomlinson, Maria Popp, Erica M. Wood, Cynthia So-Osman, David J. Roberts, Zoe McQuilten, Nicole Skoetz, Nina Kreuzberger

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

Original language	English
Article number	CD014945
Journal	The Cochrane database of systematic reviews
Volume	2021
Issue number	5
DOIs	https://doi.org/10.1002/14651858.CD014945
Publication status	Published - 20 May 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Access to Document

10.1002/14651858.CD014945

Cite this

Hirsch, C., Valk, S. J., Piechotta, V., Chai, K. L., Estcourt, L. J., Monsef, I., Salomon, S., Tomlinson, E., Popp, M., Wood, E. M., So-Osman, C., Roberts, D. J., McQuilten, Z., Skoetz, N., & Kreuzberger, N. (2021). SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. The Cochrane database of systematic reviews, 2021(5), Article CD014945. https://doi.org/10.1002/14651858.CD014945

@article{2f9b0395e05d47cbb097327ed90fd949,

title = "SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.",

author = "Caroline Hirsch and Valk, {Sarah J.} and Vanessa Piechotta and Chai, {Khai Li} and Estcourt, {Lise J.} and Ina Monsef and Susanne Salomon and Eve Tomlinson and Maria Popp and Wood, {Erica M.} and Cynthia So-Osman and Roberts, {David J.} and Zoe McQuilten and Nicole Skoetz and Nina Kreuzberger",

note = "Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = may,

day = "20",

doi = "10.1002/14651858.CD014945",

language = "English",

volume = "2021",

journal = "The Cochrane database of systematic reviews",

issn = "1465-1858",

publisher = "Cochrane Collaboration",

number = "5",

}

Hirsch, C, Valk, SJ, Piechotta, V, Chai, KL, Estcourt, LJ, Monsef, I, Salomon, S, Tomlinson, E, Popp, M, Wood, EM, So-Osman, C, Roberts, DJ, McQuilten, Z, Skoetz, N & Kreuzberger, N 2021, 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19', The Cochrane database of systematic reviews, vol. 2021, no. 5, CD014945. https://doi.org/10.1002/14651858.CD014945

TY - JOUR

T1 - SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19

AU - Hirsch, Caroline

AU - Valk, Sarah J.

AU - Piechotta, Vanessa

AU - Chai, Khai Li

AU - Estcourt, Lise J.

AU - Monsef, Ina

AU - Salomon, Susanne

AU - Tomlinson, Eve

AU - Popp, Maria

AU - Wood, Erica M.

AU - So-Osman, Cynthia

AU - Roberts, David J.

AU - McQuilten, Zoe

AU - Skoetz, Nicole

AU - Kreuzberger, Nina

PY - 2021/5/20

Y1 - 2021/5/20

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

UR - http://www.scopus.com/inward/record.url?scp=85106205126&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD014945

DO - 10.1002/14651858.CD014945

M3 - Article

AN - SCOPUS:85106205126

SN - 1465-1858

VL - 2021

JO - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

IS - 5

M1 - CD014945

ER -

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this